9 Meters Biopharma, Inc. financial data

Symbol
NMTRQ on OTC
Industry
Pharmaceutical Preparations
Location
4509 Creedmoor Road, Suite 600, Raleigh, North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INNOVATE BIOPHARMACEUTICALS, INC. (to 5/5/2020), Monster Digital, Inc. (to 1/11/2018), Tandon Digital, Inc. (to 8/12/2015)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % -80.5%
Debt-to-equity 267 % +1450%
Return On Equity -585 % -520%
Return On Assets -159 % -98%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.3 M shares -94.4%
Common Stock, Shares, Outstanding 14.3 M shares -94.4%
Entity Public Float 67.2 M USD -75.6%
Common Stock, Value, Issued 1.43 K USD -94.4%
Weighted Average Number of Shares Outstanding, Basic 13.6 M shares +5.27%
Weighted Average Number of Shares Outstanding, Diluted 13.6 M shares +5.27%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 11 M USD +5.28%
Operating Income (Loss) -43.4 M USD -1.67%
Nonoperating Income (Expense) -2.84 M USD -10627%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -46.3 M USD -8.39%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -46.3 M USD -8.39%
Earnings Per Share, Basic -3.52 USD/shares +9.28%
Earnings Per Share, Diluted -3.52 USD/shares +9.28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.94 M USD -81.4%
Assets, Current 9.2 M USD -76.5%
Property, Plant and Equipment, Net 9.08 K USD -47.5%
Operating Lease, Right-of-Use Asset 97.7 K USD -36.4%
Other Assets, Noncurrent 8.98 K USD +60.9%
Assets 9.31 M USD -76.3%
Accounts Payable, Current 4.23 M USD +121%
Employee-related Liabilities, Current 1.57 M USD +37%
Accrued Liabilities, Current 5.76 M USD -7.97%
Liabilities, Current 15.6 M USD +89.4%
Operating Lease, Liability, Noncurrent 34.8 K USD -64.7%
Liabilities 15.6 M USD +87.6%
Retained Earnings (Accumulated Deficit) -226 M USD -25.7%
Stockholders' Equity Attributable to Parent -6.3 M USD -120%
Liabilities and Equity 9.31 M USD -76.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.75 M USD -0.01%
Net Cash Provided by (Used in) Financing Activities -12.3 M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 550 M shares 0%
Common Stock, Shares, Issued 14.3 M shares -94.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22 M USD -126%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.62 M USD -79.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 174 K USD
Deferred Tax Assets, Valuation Allowance 42.6 M USD +27.3%
Operating Lease, Liability 98.4 K USD -36.5%
Depreciation 1.33 K USD -18.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 108 K USD -40%
Property, Plant and Equipment, Gross 88 K USD +3.34%
Operating Lease, Liability, Current 63.6 K USD +12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 54 K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 54 K USD -25%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.61 K USD -61.8%
Deferred Tax Assets, Operating Loss Carryforwards 21.4 M USD +14.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 100 K USD 0%
Additional Paid in Capital 220 M USD +4.3%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.99 M USD +48.6%
Interest Expense 3.42 M USD +99661%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%